SteadyMed Ltd. (STDY) Stock Analysis
DELISTED 2018
What happened to SteadyMed Ltd. (STDY) stock?
SteadyMed Ltd. (STDY) no longer trades on public markets. It was delisted in August 2018. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SteadyMed Ltd. (STDY) trades at $4.72. SteadyMed Ltd. Detailed information regarding its specific operations, financial performance, and strategic direction is currently unavailable. Sector: Unknown.
Last analyzed: Mar 16, 2026Analyst Coverage for STDY: STDY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates STDY against Unknown peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
SteadyMed Ltd. (STDY) Business Overview & Investment Profile
SteadyMed Ltd., operating in an unknown sector, lacks publicly available information to ascertain its market position or competitive advantages. With limited data, a comprehensive evaluation of its financial standing and operational efficacy remains challenging, hindering the formulation of a robust investment thesis or comparative industry analysis.
What Is the Investment Thesis for STDY?
Due to the lack of available information, formulating a comprehensive investment thesis for SteadyMed Ltd. is not possible. Key value drivers, potential growth catalysts, and associated risk factors cannot be identified or assessed. Without financial data, operational metrics, and industry insights, it is impossible to determine the company's intrinsic value, its growth potential, or its risk profile. A sound investment thesis requires a thorough understanding of the company's business model, its competitive advantages, and its management team. However, in the case of SteadyMed Ltd., this information is currently unavailable, precluding any informed investment decision.
Based on FMP financials and quantitative analysis
STDY Key Highlights
Due to lack of available financial data, key highlights cannot be determined.
- Due to lack of available financial data, key highlights cannot be determined.
- Due to lack of available financial data, key highlights cannot be determined.
- Due to lack of available financial data, key highlights cannot be determined.
- Due to lack of available financial data, key highlights cannot be determined.
What Are STDY's Key Strengths?
Information not available
- Information not available
- Information not available
- Information not available
What Are STDY's Weaknesses?
Information not available
What Could Drive STDY Stock Higher?
Information not available
- Information not available
- Information not available
- Information not available
- Information not available
What Are the Key Risks for STDY?
Insider selling — insiders were net sellers of roughly $13.7M recently.
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
What Are the Growth Opportunities for STDY?
- Due to a lack of information regarding SteadyMed Ltd.'s operations, identifying and evaluating potential growth opportunities is not possible. Market size, timeline, and competitive advantages associated with any potential growth initiatives remain unknown.
- Due to a lack of information regarding SteadyMed Ltd.'s operations, identifying and evaluating potential growth opportunities is not possible. Market size, timeline, and competitive advantages associated with any potential growth initiatives remain unknown.
- Due to a lack of information regarding SteadyMed Ltd.'s operations, identifying and evaluating potential growth opportunities is not possible. Market size, timeline, and competitive advantages associated with any potential growth initiatives remain unknown.
- Due to a lack of information regarding SteadyMed Ltd.'s operations, identifying and evaluating potential growth opportunities is not possible. Market size, timeline, and competitive advantages associated with any potential growth initiatives remain unknown.
- Due to a lack of information regarding SteadyMed Ltd.'s operations, identifying and evaluating potential growth opportunities is not possible. Market size, timeline, and competitive advantages associated with any potential growth initiatives remain unknown.
What Opportunities Does STDY Have?
- Information not available
- Information not available
- Information not available
- Information not available
What Threats Does STDY Face?
- Information not available
- Information not available
- Information not available
- Information not available
What Are STDY's Competitive Advantages?
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
What Does STDY Do?
Information regarding the founding story and evolution of SteadyMed Ltd. is currently unavailable. Consequently, it is impossible to detail the company's journey, its pivotal moments, or the strategic decisions that have shaped its current market position. The specifics of SteadyMed's products and services, its target markets, and its geographic reach also remain undefined. Without this foundational knowledge, a comprehensive understanding of the company's operations and its value proposition is not possible. Further complicating matters, insights into SteadyMed's competitive landscape, its key competitors, and its differentiating factors are also lacking. This absence of information makes it difficult to assess the company's strengths, weaknesses, opportunities, and threats within its operating environment. A thorough analysis would typically involve examining the company's revenue streams, its cost structure, and its profitability metrics. However, in the absence of financial data, such an analysis is not feasible.
What Products and Services Does STDY Offer?
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
How Does STDY Make Money?
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
What Industry Does STDY Operate In?
Without knowing the specific industry in which SteadyMed Ltd. operates, it is impossible to provide a meaningful industry context. Market trends, competitive landscape, and the company's positioning within the industry cannot be assessed. Industry growth rates, market size, and key drivers of demand remain unknown. A comprehensive industry analysis would typically involve examining the competitive dynamics, the regulatory environment, and the technological trends shaping the industry. However, in the absence of this information, such an analysis is not feasible.
Who Are STDY's Key Customers?
- Information not available
- Information not available
- Information not available
- Information not available
- Information not available
Company Profile
SteadyMed Ltd. operates in the Biotechnology industry within the Healthcare sector. STDY has traded publicly since 2015.
Key Financial Metrics
Return on assets is -60.3%, showing how much profit it generates from its asset base. A current ratio of 11.96 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -20.1%, the inverse of the P/E and a quick read on earnings relative to price.
Insider Activity
The most recent 12 insider filings for SteadyMed Ltd. break down as 11 sales and 1 purchases. On net that is roughly 3.0M shares disposed (about $13.7M), a signal worth weighing alongside the fundamentals.
STDY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Information not available
- Information not available
Bear Case
- Information not available
- Information not available
- Information not available
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
STDY Latest News
No recent news available for STDY.
Classification
Industry UnknownCommon Questions About STDY (Unknown)
What happened to SteadyMed Ltd. (STDY) stock?
SteadyMed Ltd. (STDY) no longer trades on public markets. It was delisted in August 2018. The figures below are historical and are not a current quote.
Can I still buy STDY shares?
No. STDY stopped trading on public markets in August 2018, so the shares are not available through a broker. Anything you see quoted for STDY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before STDY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to SteadyMed Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does SteadyMed Ltd. do?
Due to the lack of available information, it is impossible to provide a comprehensive explanation of SteadyMed Ltd.'s business model, products, and market position. The company's specific activities, target markets, and value proposition remain undefined. A thorough understanding of the company's operations is necessary to answer this question adequately.
What are the main risks for STDY?
Without detailed information about SteadyMed Ltd.'s operations, industry, and financial standing, a comprehensive risk analysis is not possible. Potential risks related to competition, regulation, technology, and market conditions cannot be identified or assessed. A thorough understanding of the company's business model and its operating environment is necessary to evaluate its risk profile.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available. This report is based on publicly available data, which is scarce. Further research is needed to validate these findings.